Tag bm [187 articles] Export

Recent papers classified by the tag bm.

	Menu Costs and Phillips Curves [My Copy] Journal of Political Economy, Vol. 115, No. 2. (1 April 2007), pp. 171-199. by Mikhail Golosov, Lucas Jr posted to theory rigidprice rigid phillips monet inflation bm a by adriennegret on 2009-10-27 15:55:58 as
	A comparison between basilar membrane and inner hair cell receptor potential input--output functions in the guinea pig cochlea [My Copy] The Journal of the Acoustical Society of America, Vol. 74, No. 6. (1983), pp. 1734-1741. by R. Patuzzi, P. M. Sellick posted to nuria membrane ihcrp ihc bm basilar by marekrud on 2009-10-27 14:46:53 as along with 1 person senis000
	Monetary union without fiscal coordination may discipline policymakers [My Copy] Journal of International Economics, Vol. 45, No. 2. (1 August 1998), pp. 239-258. by R. Beetsma posted to theory fisc-monet f4 emu e6 e5 coordination bm by adriennegret on 2009-10-27 07:48:29 as
	Muscle Regeneration by Bone Marrow-Derived Myogenic Progenitors [My Copy] Science, Vol. 279, No. 5356. (6 March 1998), pp. 1528-1530. by Giuliana Ferrari, Gabriella Cusella-, De Angelis, et al.Marcello Coletta, Egle Paolucci, Anna Stornaiuolo, Giulio Cossu, Fulvio Mavilio posted to bm muscle myogenic progenitor regeneration by whz2emuch on 2009-08-09 01:13:29 as along with 1 person finalversion
	HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. [My Copy] Cancer cell, Vol. 13, No. 3. (March 2008), pp. 206-220. by Rose Du, Kan V. Lu, Claudia Petritsch, et al.Patty Liu, Ruth Ganss, Emmanuelle Passegué, Hanqiu Song, Scott Vandenberg, Randall S. Johnson, Zena Werb, Gabriele Bergers posted to angiogenesis bm hif by whz2emuch on 2009-08-05 20:14:26 as along with 1 person td206
	Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. [My Copy] Stem cells (Dayton, Ohio), Vol. 22, No. 7. (2004), pp. 1292-1304. by Richard I. Sherwood, Julie L. Christensen, Irving L. Weissman, Amy J. Wagers posted to bm hsc muscle stem by whz2emuch on 2009-08-05 20:05:34 as
	A human nonlinear cochlear filterbank [My Copy] The Journal of the Acoustical Society of America, Vol. 110, No. 6. (2001), pp. 3107-3118. by Enrique A. Lopez Poveda, Ray Meddis posted to basilar bm drnl filter human membrane model by marekrud on 2009-07-02 19:34:04 as
	Further studies on the dual-resonance nonlinear filter model of cochlear frequency selectivity: Responses to tones [My Copy] The Journal of the Acoustical Society of America, Vol. 122, No. 4. (2007), pp. 2124-2134. by Alberto L. Najera, Enrique A. Lopez Poveda, Ray Meddis posted to basilar bm drnl membrane model tone by marekrud on 2009-07-01 15:15:25 as
	A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127 [My Copy] Nature Immunology, Vol. 7, No. 11. (01 October 2006), pp. 1217-1224. by Christian A. J. Vosshenrich, Marcos E. García-Ojeda, Sandrine I. Samson-Villéger, et al.Valerie Pasqualetto, Laurence Enault, Odile R. Goff, Erwan Corcuff, Delphine Guy-Grand, Benedita Rocha, Ana Cumano, Lars Rogge, Sophie Ezine, James P. Di Santo posted to bm dev nkcells thymus by ajaymalik on 2009-06-19 21:43:31 as
	'The body does not lie': Identity, risk and trust in technoculture [My Copy] Crime Media Culture, Vol. 2, No. 2. (1 August 2006), pp. 143-158. by Katja F. Aas posted to bm fdp by H-Arrietaumn on 2009-06-09 11:45:09 as along with 2 people tcb keeleer
	Twenty Years of Unrelated Donor Bone Marrow Transplantation for Pediatric Acute Leukemia Facilitated by the National Marrow Donor Program [My Copy] Biology of Blood and Marrow Transplantation, Vol. 14, No. 9. (September 2008), pp. 16-22. by M. Macmillan posted to bm demand paediatric review by TristanSmith on 2009-06-04 01:47:01 as
	Eleven million donors in bone marrow donors worldwide! Time for reassessment? [My Copy] Bone Marrow Transplantation, Vol. 41, No. 1. (2008), pp. 1-9. by J. J. van Rood, M. Oudshoorn posted to bm bmt inventory mismatch supply by TristanSmith on 2009-06-04 01:20:42 as
	Adult umbilical cord blood transplantation: a comprehensive review [My Copy] Bone Marrow Transplantation, Vol. 38, No. 1. (2006), pp. 83-93. by H. Schoemans, K. Theunissen, J. Maertens, M. Boogaerts, C. Verfaillie, J. Wagner posted to bank bm cord demand review by TristanSmith on 2009-06-04 01:17:13 as
	Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome [My Copy] Blood, Vol. 104, No. 7. (1 October 2004), pp. 1923-1930. by Neal Flomenberg, Lee A. Baxter-Lowe, Dennis Confer, et al.Marcelo Fernandez-Vina, Alexandra Filipovich, Mary Horowitz, Carolyn Hurley, Craig Kollman, Claudio Anasetti, Harriet Noreen, Ann Begovich, William Hildebrand, Effie Petersdorf, Barbara Schmeckpeper, Michelle Setterholm, Elizabeth Trachtenberg, Thomas Williams, Edmond Yunis, Daniel Weisdorf posted to bm hla-c mismatch outcome pb typing by TristanSmith on 2009-06-03 03:20:46 as along with 1 person peters
	Donor Characteristics Affecting Graft Failure and Survival after Unrelated Donor Transplantation with Reduced Intensity Conditioning Regimens (RIC) for Hematologic Malignancies. [My Copy] ASH Annual Meeting Abstracts, Vol. 112, No. 11. (16 November 2008), 1968. by Jakob R. Passweg, Fangyu Kan, Mei-Jie Zhang, et al.Vanderson Rocha, Luis M. Isola, Adrian P. Gee, John Gibson, Hillard M. Lazarus, Mary J. Laughlin, Alison Loren, David Marks, Alois Gratwohl, Mary Eapen posted to bm pb ric demand by TristanSmith on 2009-06-03 02:34:45 as
	Effect of Stem Cell Source on Transplant Outcomes in Adults with Acute Leukemia: A Comparison of Unrelated Bone Marrow (BM), Peripheral Blood (PB) and Cord Blood (CB) [My Copy] ASH Annual Meeting Abstracts, Vol. 112, No. 11. (16 November 2008), 151. by Mary Eapen, Vanderson Rocha, Andromachi Scaradavou, et al.Eliane Gluckman, Mary Laughlin, Cladd Stevens, Mary M. Horowitz, John E. Wagner posted to blood bm cb comparisons cord outcome pb demand by TristanSmith on 2009-06-03 01:04:13 as
	Optimum Currency Areas [My Copy] The American Economic Review, Vol. 53, No. 4. (1963), pp. 717-725. by Ronald I. Mckinnon posted to theory oca bm a by adriennegret on 2009-05-26 09:38:41 as
	A Theory of Optimum Currency Areas [My Copy] The American Economic Review, Vol. 51, No. 4. (1961), pp. 657-665. by Robert A. Mundell posted to trade theory oca bm a by adriennegret on 2009-05-26 09:34:25 as along with 1 person troelskd
	The Modern History of Exchange Rate Arrangements: A Reinterpretation [My Copy] Social Science Research Network Working Paper Series (30 May 2002) by Carmen M. Reinhart, Kenneth S. Rogoff posted to history f4 f3 er emetr bm by adriennegret on 2009-05-13 11:18:52 as
	Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials. [My Copy] Cancer, Vol. 110, No. 7. (20 August 2007), pp. 1621-1628. by David R R. Buchanan, Ann M M. O'mara, Joseph W W. Kelaghan, Maria Sgambati, Worta McCaskill-Stevens, Lori Minasian posted to quality_of_life quality oncology bm by worx11 to the group XROWXR on 2007-09-21 17:19:50 as along with 1 person suizan
	Fast Inversion of Hankel Systems and Efficient BCH Decoding [My Copy] by Michael Schmidt, Gerhard P. Fettweis posted to bm hankel by pbarry on 2007-09-21 11:37:53 as
	Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom. [My Copy] Clin Ther, Vol. 27, No. 8. (August 2005), pp. 1295-1310. by E. De Cock, J. Hutton, P. Canney, et al.J. J. Body, P. Barrett-Lee, M. P. Neary, G. Lewis posted to outcomes oncology cost-effectiveness bm by worx11 to the group XROWXR on 2007-09-20 20:23:29 as
	Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy. [My Copy] Support Care Cancer, Vol. 13, No. 12. (December 2005), pp. 975-986. by E. De Cock, J. Hutton, P. Canney, et al.J. J. Body, P. Barrett-Lee, M. P. Neary, G. Lewis posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 20:21:31 as along with 1 group XROWXR
	The Medicare Prescription Drug Improvement and Modernization Act and the delivery of cancer chemotherapy. [My Copy] Am J Health Syst Pharm, Vol. 64, No. 15 Suppl 10. (1 August 2007) by C. Downs posted to bm medicare medicare_part_d oncology by worx11 on 2007-09-20 20:17:29 as along with 1 group XROWXR
	Formulary issues at a pediatric hospital: experience at Children's National Medical Center. [My Copy] Hosp Formul, Vol. 26, No. 6. (June 1991), pp. 500-510. by G. J. Cohen, S. J. Allen posted to bm formulary oncology outcomes by worx11 on 2007-09-20 20:14:23 as along with 1 group XROWXR
	Many new cancer drugs in the United Kingdom are facing negative NICE rulings. [My Copy] J Clin Oncol, Vol. 25, No. 18. (20 June 2007) by E. Low, posted to outcomes oncology bm by worx11 to the group XROWXR on 2007-09-20 20:11:50 as
	European perspective on the costs and cost-effectiveness of cancer therapies. [My Copy] J Clin Oncol, Vol. 25, No. 2. (10 January 2007), pp. 191-195. by M. F. Drummond, A. R. Mason posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 20:08:00 as along with 1 group XROWXR
	Cost-utility analysis of imatinib mesilate for the treatment of advanced stage chronic myeloid leukaemia. [My Copy] Br J Cancer, Vol. 89, No. 4. (18 August 2003), pp. 634-640. by A. Gordois, P. Scuffham, E. Warren, S. Ward posted to bm cost-utility oncology outcomes by worx11 on 2007-09-20 19:30:11 as along with 1 group XROWXR
	Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. [My Copy] Health Technol Assess, Vol. 8, No. 28. (July 2004) by K. Dalziel, A. Round, K. Stein, R. Garside, A. Price posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:27:43 as along with 1 group XROWXR
	Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia. [My Copy] Pharmacoeconomics, Vol. 23, No. 5. (2005), pp. 515-526. by K. Dalziel, A. Round, R. Garside, K. Stein posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:27:07 as along with 1 group XROWXR
	Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase. [My Copy] Clin Ther, Vol. 26, No. 11. (November 2004), pp. 1924-1933. by E. Warren, S. Ward, A. Gordois, P. Scuffham posted to bm cost-utility oncology outcomes by worx11 on 2007-09-20 19:25:17 as along with 1 group XROWXR
	Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service. [My Copy] Clin Ther, Vol. 26, No. 9. (September 2004), pp. 1546-1561. by M. Marchetti, M. Caruggi, G. Colombo posted to outcomes oncology cost-utility budget_impact bm by worx11 to the group XROWXR on 2007-09-20 19:23:02 as
	Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumours. [My Copy] Clin Drug Investig, Vol. 27, No. 2. (2007), pp. 85-93. by D. M. Huse, M. von Mehren, G. Lenhart, et al.H. Joensuu, C. Blanke, W. Feng, S. Finkelstein, G. Demetri posted to outcomes oncology cost-effectiveness bm by worx11 to the group XROWXR on 2007-09-20 19:21:12 as along with 1 person Terkko
	Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer. [My Copy] Clin Breast Cancer, Vol. 7, No. 8. (June 2007), pp. 608-618. by T. E. Delea, J. Karnon, O. Sofrygin, S. K. Thomas, N. L. Papo, V. Barghout posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:18:02 as along with 1 group XROWXR
	Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective. [My Copy] Pharmacoeconomics, Vol. 24, No. 3. (2006), pp. 237-250. by J. Karnon, T. Delea, S. R. Johnston, et al.R. Smith, J. Brandman, J. Sung, P. E. Goss posted to outcomes oncology cost-effectiveness bm by worx11 to the group XROWXR on 2007-09-20 19:16:06 as
	Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen. [My Copy] Am J Clin Oncol, Vol. 26, No. 3. (June 2003), pp. 289-296. by G. Dranitsaris, S. Verma, M. Trudeau posted to oncology cost-utility bm by worx11 to the group XROWXR on 2007-09-20 19:15:12 as
	Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole. [My Copy] Breast, Vol. 16, No. 3. (June 2007), pp. 252-261. by C. Skedgel, D. Rayson, R. Dewar, T. Younis posted to bm cost-utility oncology outcomes by worx11 on 2007-09-20 19:02:57 as along with 1 group XROWXR
	Reimbursement for cancer treatment: coverage of off-label drug indications. [My Copy] J Clin Oncol, Vol. 24, No. 19. (1 July 2006), pp. 3206-3208. by posted to oncology bm by worx11 to the group XROWXR on 2007-09-20 18:57:10 as
	Cost considerations in the management of cancer in the older patient. [My Copy] Oncology (Williston Park), Vol. 21, No. 7. (June 2007) by J. M. McKoy, K. A. Fitzner, B. J. Edwards, et al.M. Alkhatib, C. C. Tigue, N. J. Nonzee, C. R. Bolden, C. L. Bennett posted to outcomes oncology bm by worx11 to the group XROWXR on 2007-09-20 18:54:02 as
	Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate. [My Copy] Am J Manag Care, Vol. 13, No. 6 Pt 2. (June 2007), pp. 347-352. by D. E. Mager, E. R. Cox posted to benefit_design bm by worx11 on 2007-09-20 17:46:48 as along with 1 group XROWXR
	Health plans' strategies for managing outpatient specialty pharmaceuticals. [My Copy] Health Aff (Millwood), Vol. 25, No. 5. (t 2006), pp. 1332-1339. by C. D. Mullins, D. C. Lavallee, F. G. Pradel, A. R. DeVries, N. Caputo posted to benefit_design bm by worx11 on 2007-09-20 15:58:39 as along with 1 person and 1 group NCCNHealthPolicyGroup XROWXR
	Pharmacy benefit caps and the chronically ill. [My Copy] Health Aff (Millwood), Vol. 26, No. 5. (t 2007), pp. 1333-1344. by G. F. Joyce, D. P. Goldman, P. Karaca-Mandic, Y. Zheng posted to bm benefit_design by worx11 to the group XROWXR on 2007-09-20 15:45:58 as
	Major changes in benefit design: a plausible way to control costs? [My Copy] Find Brief, Vol. 9, No. 6. (November 2006), pp. 1-6. by C. Demchak posted to bm benefit_design by worx11 to the group XROWXR on 2007-09-20 15:30:28 as
	Insurers' strategies for managing the use and cost of biopharmaceuticals. [My Copy] Health Aff (Millwood), Vol. 25, No. 5. (t 2006), pp. 1205-1217. by J. C. Robinson posted to bm benefit_design by worx11 to the group XROWXR on 2007-09-20 15:27:18 as along with 1 person NCCNHealthPolicyGroup
	Employer benefit design considerations for the era of biotech drugs. [My Copy] J Occup Environ Med, Vol. 49, No. 6. (June 2007), pp. 626-632. by F. R. Vogenberg, J. P. Holland, D. Liebeskind posted to bm benefit_design by worx11 to the group XROWXR on 2007-09-20 15:22:55 as
	Specialty pharmacy cost management strategies of private health care payers. [My Copy] J Manag Care Pharm, Vol. 12, No. 9. (c 2006), pp. 736-744. by D. Stern, D. Reissman posted to benefit_design bm by worx11 on 2007-09-20 15:19:38 as along with 1 group XROWXR
	Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy. [My Copy] J Manag Care Pharm, Vol. 13, No. 3. (April 2007), pp. 235-244. by K. Yokoyama, W. Yang, R. Preblick, F. Frech-Tamas posted to bm benefit_design by worx11 to the group XROWXR on 2007-09-20 15:18:19 as
	Controlling prescription drug expenditures: a report of success. [My Copy] Am J Manag Care, Vol. 13, No. 8. (August 2007), pp. 473-480. by D. P. Miller, C. D. Furberg, R. H. Small, et al.F. M. Millman, W. T. Ambrosius, J. S. Harshbarger, C. A. Ohl posted to bm benefit_design by worx11 to the group XROWXR on 2007-09-20 15:16:53 as
	Effects of benefit design change across 5 disease states. [My Copy] Am J Manag Care, Vol. 13, No. 6 Pt 2. (June 2007), pp. 370-376. by D. I. Brixner, V. N. Joish, G. M. Odera, S. G. Avey, D. M. Hanson, H. E. Cannon posted to bm benefit_design by worx11 to the group XROWXR on 2007-09-20 15:14:00 as
	Incentive formularies and changes in prescription drug spending. [My Copy] Am J Manag Care, Vol. 13, No. 6 Pt 2. (June 2007), pp. 360-369. by B. E. Landon, M. B. Rosenthal, S. L. Normand, et al.C. Spettell, A. Lessler, H. R. Underwood, J. P. Newhouse posted to bm benefit_design by worx11 to the group XROWXR on 2007-09-20 15:12:45 as

Note: You may cite this page as: http://www.citeulike.org/tag/bm

Result page: 1 2 3 4 Next

senior_care_research	188
skilled_nursing_facility	68
snf	66
jmcp_manuscript	62
cmrf	60
long_term_care	60
diabetes	58
medicare	58
nursing_facility	58
nursing_home	56
medicare_part_d	52
cost-effectiveness	46
benefit_design	40
home_healthcare	40
oncology	38
outcomes	32
caregiving	24
quality	22
assisted_living	18
medication_therapy_management	18
mtm	12
cost-utility	10
demand	8
medicaid	8
file-import-09-06-09	6
pb	6
pharmacist	6
cord	4
formulary	4
mismatch	4
outcome	4
regulatory	4
review	4
theory	4
basilar	3
biomass	3
dielectrics	3
membrane	3
bank	2
blood	2
bmt	2
budget_impact	2
cb	2
comparisons	2
drnl	2
evidence_based	2
exenatide	2
f4	2
generic	2
hla-c	2
hospital	2
inventory	2
me	2
model	2
muscle	2
oca	2
paediatric	2
quality_of_life	2
rehabilitation	2
ric	2
supply	2
typing	2
angiogenesis	1
coordination	1
dev	1
e5	1
e6	1
emetr	1
emu	1
er	1
f3	1
fdp	1
filter	1
fisc-monet	1
hankel	1
hif	1
history	1
hsc	1
human	1
ihc	1
ihcrp	1
inflation	1
matching	1
monet	1
myogenic	1
nkcells	1
nuria	1
pattern	1
phillips	1
progenitor	1
regeneration	1
rigid	1
rigidprice	1
stem	1
thymus	1
tone	1
trade	1

Tag bm [187 articles] Export

Related Tags